Home > Riviste > Minerva Urology and Nephrology > Fascicoli precedenti > Minerva Urology and Nephrology 2021 August;73(4) > Minerva Urology and Nephrology 2021 August;73(4):424-7

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

MINERVA OPINION EDITORIAL   

Minerva Urology and Nephrology 2021 August;73(4):424-7

DOI: 10.23736/S2724-6051.21.04592-4

Copyright © 2021 EDIZIONI MINERVA MEDICA

lingua: Inglese

Potential utility of a 4-marker immunohistochemistry panel to predict response to cisplatin-based neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: a single-center preliminary experience

Simone MORSELLI 1, 2 , Riccardo CAMPI 1, 2, Mauro GACCI 1, 2, Arcangelo SEBASTIANELLI 1, 2, Caterina FATTORINI 3, Donata VILLARI 1, 2, Marco CARINI 2, 4, Andrea MINERVINI 2, 4, Sergio SERNI 1, 2, Maria R. RASPOLLINI 3

1 Unit of Urological Robotic Surgery and Renal Transplantation, Careggi Hospital, University of Florence, Florence, Italy; 2 Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; 3 Department of Histopathology and Molecular Diagnostics, Careggi Hospital, University of Florence, Florence, Italy; 4 Unit of Urological Oncologic Minimally-Invasive Robotic Surgery and Andrology, Careggi Hospital, University of Florence, Florence, Italy



inizio pagina